Global COVID-19 Vaccine Packaging And Delivery Devices Market by Product (Vials, Syringes) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Summary of the Report

Global COVID-19 vaccine packaging market was worth USD 962.0 millions in 2021. It is expected to grow at a compound annual rate (CAGR of 5.4%) between 2022 and 2028. The vaccines are packaged in multidose glass vials, just like other pharmaceutical liquid formulations. To avoid wastage, packaging will be required for distribution. The factors that are expected to drive the growth of the COVID-19 vaccine packaging market and delivery devices will be the speeding of rollouts, increasing production capacity, and a substantial number of vaccines in late stages of clinical approvals. More than 50% of Americans 65 and older have been fully vaccinated as of April 2021.

To meet increasing global demand, manufacturers are increasing their production capacity. The demand for packaging materials will rise due to the increased production capacity. AstraZeneca and IDT Biologika have partnered to create a new German manufacturing facility in February 2021. IDT biological is a German contract researcher manufacturer that also produces and fills glass vials. Market growth will be accelerated by the rapid rate at which the virus is evolving into a more dangerous strain.

The market for COVID-19 vaccine packaging will grow as more investment is made in R&D in order to create packaging materials with superior chemical resistance and material strength. Corning Incorporated has developed a unique glass vial, called "Valor". This unique glass vial has many advantages over traditional borosilicate vials. Valor glass vials offer many benefits, including delamination resistance, breakage resistance and reduced particulate generation.

The Our World in Data report estimates that around 270 million COVID-19 vaccines were administered worldwide between March 4th, 2021 and March 4th, 2021. Around 30% of all vaccines were administered in the United States. Many countries are vaccinating at a faster rate than the rest, which will increase demand. To support vaccine campaigns, the U.S. government gave BD an order to supply 50,000,000 needles and syringes.

Product Insights

In 2021, the market leader in COVID-19 vaccine packaging delivery devices was the syringes category. The segment held the largest revenue share at 61.5%. This segment can be further divided into empty and filled syringes. A single COVID-19 dose has a volume of approximately 0.5 ml. Therefore, it is preferable to use 1.0 ml empty sterile syringes. Some vaccine candidates need to be reconstituted with diluent solution before administration. In such cases, an additional empty syringe (3/3 ml), is necessary. Pfizer has developed a vaccine that must be reconstituted using saline. This will have a significant impact on the segment's roll-out.

Prefilled syringes is expected to see the fastest growth over the forecast period. With the existing logistic network, it is possible to vaccinate the entire 7.0 billion population of the world in less time. Prefilled syringes will be more popular due to the distribution limitations of COVID-19-related packaging systems. BD, for example, invested USD 1.2 million in December 2020 to increase their pre-filled syringe manufacturing capacity.

There are two types of vials: plastic and glass. Because vaccine components interact with the plastic vial's polymers, it is not often used for storage of biological liquids. Type 1 borosilicate glasses vials can be used for COVID-19 vaccine storage. There is a large gap between the supply and demand of glass vials. This will likely increase the demand for plastic vials. SiO2 Materials Science has developed plastic vials that are shatterproof and strong. This could be an alternative to glass vials in the future.

Regional Insights

North America was the dominant market for COVID-19 vaccine delivery devices and packaging. In 2021, it held the largest revenue share at 39.3%. The CDC data shows that 15.9% of the U.S. population received a single dose COVID-19 vaccine up to March 20, 2021. 8.1% have been fully vaccinated. Operation Wrap Speed, Biomedical Advanced Research & Development Authority (BARDA), Defense Production Act (DPA), among others, are expected to accelerate the production and distribution COVID-19 vaccines. This will increase the demand for packaging material.

The market for COVID-19 delivery devices and vaccine packaging in Europe accounted for the second largest revenue share in 2021. It has strong vaccine production and packaging facilities. One of the main factors driving the growth of the COVID-19 vaccine packaging market and delivery devices is the growing concern among EU member states about maintaining a comparable vaccination rate to countries like the U.K. and U.S. To boost EU supply, BioNTech, a German vaccine company, will begin production of COVID-19 vaccine in its new German production facility in February 2021.

Asia Pacific is expected to see the fastest growth in the market for COVID-19 vaccination packaging and delivery devices over the forecast period. China, India and Korea are the most important markets for COVID-19 delivery device and packaging manufacturers. To increase their revenue, Asian vial manufacturers are rapidly expanding their production capacity as tight supplies threaten the global delivery of vaccines. According to the China Vaccine Industry Association, (CVIA), this year's annual glass vial production will reach 8.0 billion.

Market Share Insights & Key Companies

It is common for the top companies to sign long agreements with vaccine developers and national governments. In July 2020, BD signed an agreement with the U.S government to supply 140 million more injection devices. This brings the total order to 190,000,000 from BD. The Canadian government also increased its order for 75 million injection devices.

To be successful in highly competitive markets, market expansion, product differentiation and collaboration are the key strategies of market leaders. Schott Kaisha (India-based subsidiary of Schott AG) invested approximately USD 17 million in December 2020 to increase its vial manufacturing capacity to 300 million in preparation for the possible surge in demand. The market for COVID-19 vaccine packaging, delivery devices and other products is dominated by the following players:

• BD

• B. Braun Melsungen AG

• Hindustan Syringes & Medical Devices Ltd.

• Terumo

• NIPRO Medical Corporation

• SCHOTT AG

• Gerresheimer AG

• Cardinal Health

Up Market Research published a new report titled “COVID-19 Vaccine Packaging And Delivery Devices Market research report which is segmented by Product (Vials, Syringes), By Players/Companies Gerresheimer AG, SCHOTT AG, Hindustan Syringes & Medical Devices Ltd, B Braun Melsungen AG, BD, Terumo, Cardinal Health, NIPRO Medical Corporation”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

Report Scope

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global COVID-19 Vaccine Packaging And Delivery Devices Market Report Segments:

The market is segmented by Product (Vials, Syringes).

COVID-19 Vaccine Packaging And Delivery Devices Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the COVID-19 Vaccine Packaging And Delivery Devices Market

Overview of the regional outlook of the COVID-19 Vaccine Packaging And Delivery Devices Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The COVID-19 Vaccine Packaging And Delivery Devices Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of COVID-19 Vaccine Packaging And Delivery Devices Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. Vials

                2. Syringes

7. Market scenario by region, sub-region, and country.
8. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
9. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
10. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the COVID-19 Vaccine Packaging And Delivery Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the COVID-19 Vaccine Packaging And Delivery Devices Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.